236 related articles for article (PubMed ID: 15600375)
1. Introduction: the dual-action debate: does pharmacology matter?
Thase ME
J Clin Psychiatry; 2004; 65 Suppl 17():3-4. PubMed ID: 15600375
[No Abstract] [Full Text] [Related]
2. The dual-action hypothesis: does pharmacology matter?
Shelton RC
J Clin Psychiatry; 2004; 65 Suppl 17():5-10. PubMed ID: 15600376
[TBL] [Abstract][Full Text] [Related]
3. Norepinephrine involvement in antidepressant action.
Frazer A
J Clin Psychiatry; 2000; 61 Suppl 10():25-30. PubMed ID: 10910014
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants.
Frazer A
J Clin Psychiatry; 1997; 58 Suppl 6():9-25. PubMed ID: 9227669
[No Abstract] [Full Text] [Related]
5. [Escitalopram versus citalopram in true depression. Review of studies do not support clinically relevant differences of the effect].
Schwan S; Hallberg P
Lakartidningen; 2009 Mar 18-24; 106(12):858-61. PubMed ID: 19452787
[No Abstract] [Full Text] [Related]
6. [Review of antidepressants from the TCAs to the third generation drugs].
Almási J; Rihmer Z
Neuropsychopharmacol Hung; 2004 Dec; 6(4):185-94. PubMed ID: 15825674
[TBL] [Abstract][Full Text] [Related]
7. The brain tells: early signs of depression recovery.
Harv Ment Health Lett; 2002 Nov; 19(5):6. PubMed ID: 12453746
[No Abstract] [Full Text] [Related]
8. Does depression hurt?
Stahl SM
J Clin Psychiatry; 2002 Apr; 63(4):273-4. PubMed ID: 12000200
[TBL] [Abstract][Full Text] [Related]
9. Vilazodone approved for major depression.
Traynor K
Am J Health Syst Pharm; 2011 Mar; 68(5):366. PubMed ID: 21330672
[No Abstract] [Full Text] [Related]
10. [Serotonin neurotrasmission and treatment options for depression].
Sivolap YP
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):174-177. PubMed ID: 29265105
[TBL] [Abstract][Full Text] [Related]
11. Psychobiology and psychopharmacotherapy of unipolar major depression: a review.
O'Toole SM; Johnson DA
Arch Psychiatr Nurs; 1997 Dec; 11(6):304-13. PubMed ID: 9419922
[TBL] [Abstract][Full Text] [Related]
12. Vortioxetine: a New Treatment for Major Depressive Disorder.
Connolly KR; Thase ME
Expert Opin Pharmacother; 2016; 17(3):421-31. PubMed ID: 26679430
[TBL] [Abstract][Full Text] [Related]
13. Future directions for serotonin and antidepressants.
Artigas F
ACS Chem Neurosci; 2013 Jan; 4(1):5-8. PubMed ID: 23336036
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of antidepressants: selectivity or multiplicity?
Westenberg HG
J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
[TBL] [Abstract][Full Text] [Related]
15. In the treatment of depression, does selectivity of action matter?
J Clin Psychiatry; 2004; 65 Suppl 4():60-2. PubMed ID: 15046543
[No Abstract] [Full Text] [Related]
16. Effect of selective serotonin reuptake inhibitors on in vitro fertilization outcome.
Friedman BE; Rogers JL; Shahine LK; Westphal LM; Lathi RB
Fertil Steril; 2009 Oct; 92(4):1312-1314. PubMed ID: 19423105
[TBL] [Abstract][Full Text] [Related]
17. Development of new antidepressants.
Sambunaris A; Hesselink JK; Pinder R; Panagides J; Stahl SM
J Clin Psychiatry; 1997; 58 Suppl 6():40-53. PubMed ID: 9227672
[TBL] [Abstract][Full Text] [Related]
18. [Trazodone--its multifunctional mechanism of action and clinical use].
Frecska E
Neuropsychopharmacol Hung; 2010 Dec; 12(4):477-82. PubMed ID: 21220793
[TBL] [Abstract][Full Text] [Related]
19. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
Ishigooka J
Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
[TBL] [Abstract][Full Text] [Related]
20. Levomilnacipran: a newly approved drug for treatment of major depressive disorder.
Mago R; Mahajan R; Thase ME
Expert Rev Clin Pharmacol; 2014 Mar; 7(2):137-45. PubMed ID: 24524592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
